Roberta L. Hayes

2.0k total citations · 1 hit paper
16 papers, 1.6k citations indexed

About

Roberta L. Hayes is a scholar working on Immunology, Genetics and Neurology. According to data from OpenAlex, Roberta L. Hayes has authored 16 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Genetics and 5 papers in Neurology. Recurrent topics in Roberta L. Hayes's work include Glioma Diagnosis and Treatment (6 papers), Immunotherapy and Immune Responses (5 papers) and Neuroblastoma Research and Treatments (4 papers). Roberta L. Hayes is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Immunotherapy and Immune Responses (5 papers) and Neuroblastoma Research and Treatments (4 papers). Roberta L. Hayes collaborates with scholars based in United States. Roberta L. Hayes's co-authors include C.L. Edwards, Andrew K. Godwin, Jaclyn A. Biegel, Philip W. Zoltick, Gloria Ramírez, David K. Moscatello, Marina Holgado-Madruga, George R. Gunn, Albert J. Wong and Elizabeth W. Newcomb and has published in prestigious journals such as The Journal of Immunology, Cancer and Annals of the New York Academy of Sciences.

In The Last Decade

Roberta L. Hayes

16 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors.

1995 507 citations David K. Moscatello, Marina Holgado-Madruga et al. PubMed profile →

Peers

Countries citing papers authored by Roberta L. Hayes

Since Specialization

Citations

This map shows the geographic impact of Roberta L. Hayes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta L. Hayes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta L. Hayes more than expected).

Fields of papers citing papers by Roberta L. Hayes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta L. Hayes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta L. Hayes. The network helps show where Roberta L. Hayes may publish in the future.

Co-authorship network of co-authors of Roberta L. Hayes

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta L. Hayes. A scholar is included among the top collaborators of Roberta L. Hayes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta L. Hayes. Roberta L. Hayes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Treatment of refractory recurrent malignant glioma with adoptive cellular immunotherapy: a case report 2001 ·Critical Reviews in Oncology/Hematology ·Yiwu Huang, Roberta L. Hayes, (unknown), Ehud Arbit, Ronald Scheff	9
2	Adoptive cellular immunotherapy for the treatment of malignant gliomas 2001 ·Critical Reviews in Oncology/Hematology ·Roberta L. Hayes, Ehud Arbit, Marcel Odaimi, Susan C. Pannullo, Ronald Scheff, (unknown), (unknown)	45
3	A rapid method to identify cytotoxic T-lymphocyte peptide epitopes from HLA-A2 (+) donors 2001 ·Critical Reviews in Oncology/Hematology ·Mario R. Castellanos, (unknown), Roberta L. Hayes	2
4	Synthetic Peptides Induce a Cytotoxic Response against Human Papillomavirus Type-18 2001 ·Gynecologic Oncology ·Mario R. Castellanos, Roberta L. Hayes, Mitchell Maiman	10
5	Preferential Inactivation of the p53 Tumor Suppressor Pathway and Lack of EGFR Amplification Distinguish de novo High Grade Pediatric Astrocytomas from de novo Adult Astrocytomas 2000 ·Brain Pathology ·(unknown), Douglas C. Miller, Roberta L. Hayes, M. Alonso, Herman Yee, Elizabeth W. Newcomb	133
6	Survival of Patients with Glioblastoma Multiforme is not Influenced by Altered Expression of P16, P53, EGFR, MDM2 or Bcl‐2 Genes 1998 ·Brain Pathology ·Elizabeth W. Newcomb, Henry Cohen, Suzanne R. Lee, (unknown), Joanna Bloom, Roberta L. Hayes, Douglas C. Miller	155
7	bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status 1997 ·Acta Neuropathologica ·Elizabeth W. Newcomb, (unknown), (unknown), Roberta L. Hayes, Henry Cohen, Douglas C. Miller	42
8	Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma 1995 ·Cancer ·Roberta L. Hayes, Maxim Koslow, Emile Hiesiger, Kenneth B. Hymes, (unknown), (unknown), Howard S. Höchster, (unknown), Gleb N. Budzilovich, Joseph Ransohoff	145
9	Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. breakdown → 1995 ·PubMed ·David K. Moscatello, Marina Holgado-Madruga, Andrew K. Godwin, Gloria Ramírez, George R. Gunn, Philip W. Zoltick, Jaclyn A. Biegel, Roberta L. Hayes, Albert J. Wong	507
10	Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs) 1993 ·Journal of Neuro-Oncology ·Emile Hiesiger, Roberta L. Hayes, (unknown), Gleb N. Budzilovich	58
11	Cytokines Involved in the Generation of Cytolytic Effector T Lymphocytes^a 1988 ·Annals of the New York Academy of Sciences ·Janet M.D. Plate, (unknown), (unknown), Roberta L. Hayes	2
12	Pretreatment with minor histocompatibility antigens prevents the development of functional CTL helper cell activity. 1983 ·The Journal of Immunology ·Roberta L. Hayes, (unknown)	8
13	The induction of alloreactive cytotoxic responses in vivo are inhibited by pretreatment with M is-disparate cells. 1982 ·The Journal of Immunology ·Roberta L. Hayes, (unknown)	13
14	Soluble factors in tolerance and contact sensitivity to 2,4‐dinitrofluorobenzene in miceIV. Characterization of migration inhibition factor‐producing lymphocytes and genetic requirements for activation 1982 ·European Journal of Immunology ·John W. Moorhead, J W Murphy, (unknown), Roberta L. Hayes, (unknown)	3
15	The ultrastructure of skin in progressive systemic sclerosis (scleroderma). I. Dermal collagen fibers. 1971 ·PubMed ·Roberta L. Hayes, Gerald P. Rodnan	64
16	Tumor scanning with 67Ga citrate. 1969 ·PubMed ·C.L. Edwards, Roberta L. Hayes	376

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact